| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Induced Pluripotent Stem Cells | 16 | 2023 | 117 | 6.180 |
Why?
|
| Gene Expression Regulation | 46 | 2024 | 1976 | 5.940 |
Why?
|
| Quantitative Trait Loci | 34 | 2024 | 608 | 5.420 |
Why?
|
| Pan troglodytes | 18 | 2023 | 199 | 4.650 |
Why?
|
| Myocytes, Cardiac | 9 | 2022 | 314 | 3.630 |
Why?
|
| Sequence Analysis, RNA | 22 | 2022 | 233 | 3.350 |
Why?
|
| Genetic Variation | 21 | 2021 | 1374 | 3.270 |
Why?
|
| Cell Differentiation | 13 | 2024 | 1525 | 3.140 |
Why?
|
| Gene Expression Profiling | 35 | 2023 | 1431 | 2.990 |
Why?
|
| DNA Methylation | 14 | 2020 | 657 | 2.810 |
Why?
|
| Genomics | 11 | 2020 | 762 | 2.770 |
Why?
|
| Gene Expression | 13 | 2020 | 1310 | 2.650 |
Why?
|
| Primates | 10 | 2022 | 155 | 2.400 |
Why?
|
| Evolution, Molecular | 14 | 2020 | 841 | 2.370 |
Why?
|
| Cell Line | 29 | 2023 | 2496 | 2.020 |
Why?
|
| Computational Biology | 8 | 2020 | 543 | 1.940 |
Why?
|
| Single-Cell Analysis | 6 | 2024 | 148 | 1.810 |
Why?
|
| Embryoid Bodies | 2 | 2023 | 2 | 1.720 |
Why?
|
| Chromatin | 11 | 2020 | 397 | 1.680 |
Why?
|
| Epigenesis, Genetic | 10 | 2021 | 507 | 1.570 |
Why?
|
| Macaca mulatta | 6 | 2020 | 466 | 1.560 |
Why?
|
| Selection, Genetic | 6 | 2020 | 512 | 1.510 |
Why?
|
| RNA, Messenger | 13 | 2016 | 2017 | 1.450 |
Why?
|
| Species Specificity | 17 | 2020 | 684 | 1.440 |
Why?
|
| Genome, Human | 16 | 2022 | 767 | 1.260 |
Why?
|
| Humans | 97 | 2024 | 89357 | 1.160 |
Why?
|
| Animals | 43 | 2023 | 27371 | 1.130 |
Why?
|
| Polyadenylation | 3 | 2021 | 10 | 1.130 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2020 | 382 | 1.080 |
Why?
|
| Genome-Wide Association Study | 14 | 2024 | 1671 | 1.060 |
Why?
|
| Gene Regulatory Networks | 6 | 2019 | 308 | 1.050 |
Why?
|
| Transcription Factors | 13 | 2016 | 1653 | 0.970 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2020 | 481 | 0.970 |
Why?
|
| Hypoxia | 2 | 2021 | 653 | 0.970 |
Why?
|
| Histones | 6 | 2014 | 329 | 0.960 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2020 | 76 | 0.960 |
Why?
|
| Genome | 9 | 2019 | 386 | 0.950 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2020 | 153 | 0.940 |
Why?
|
| Protein Biosynthesis | 3 | 2016 | 389 | 0.920 |
Why?
|
| RNA Stability | 3 | 2014 | 89 | 0.880 |
Why?
|
| Models, Genetic | 6 | 2019 | 945 | 0.880 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2020 | 2340 | 0.860 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 191 | 0.850 |
Why?
|
| Transcriptome | 8 | 2023 | 630 | 0.840 |
Why?
|
| Metagenome | 2 | 2014 | 105 | 0.840 |
Why?
|
| Transcription, Genetic | 5 | 2014 | 1157 | 0.760 |
Why?
|
| Stress, Physiological | 2 | 2021 | 232 | 0.740 |
Why?
|
| Epigenomics | 4 | 2016 | 103 | 0.720 |
Why?
|
| Protein Domains | 1 | 2020 | 134 | 0.710 |
Why?
|
| Osteogenesis | 1 | 2022 | 255 | 0.710 |
Why?
|
| Conserved Sequence | 1 | 2020 | 211 | 0.700 |
Why?
|
| Receptors, Odorant | 3 | 2016 | 37 | 0.680 |
Why?
|
| Phenotype | 12 | 2024 | 2440 | 0.670 |
Why?
|
| Genetic Loci | 2 | 2017 | 253 | 0.650 |
Why?
|
| Phosphopeptides | 1 | 2018 | 11 | 0.640 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 8 | 0.640 |
Why?
|
| Research Design | 2 | 2020 | 599 | 0.630 |
Why?
|
| Cardiotoxicity | 1 | 2018 | 10 | 0.620 |
Why?
|
| Anthracyclines | 1 | 2018 | 38 | 0.610 |
Why?
|
| Cell Cycle | 1 | 2020 | 509 | 0.610 |
Why?
|
| Proteome | 2 | 2018 | 132 | 0.600 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 374 | 0.590 |
Why?
|
| Gene Silencing | 1 | 2018 | 178 | 0.580 |
Why?
|
| DNA Transposable Elements | 1 | 2018 | 175 | 0.580 |
Why?
|
| Phosphoproteins | 1 | 2018 | 261 | 0.570 |
Why?
|
| Liver | 5 | 2015 | 1208 | 0.560 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2014 | 46 | 0.560 |
Why?
|
| Smell | 2 | 2016 | 111 | 0.560 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2017 | 248 | 0.550 |
Why?
|
| Tuberculosis | 4 | 2017 | 121 | 0.540 |
Why?
|
| Chlorambucil | 1 | 2015 | 23 | 0.530 |
Why?
|
| Carbamates | 1 | 2015 | 15 | 0.530 |
Why?
|
| Cells, Cultured | 6 | 2024 | 2884 | 0.520 |
Why?
|
| Oxygen | 1 | 2021 | 743 | 0.520 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 44 | 0.520 |
Why?
|
| Dendritic Cells | 3 | 2017 | 449 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2018 | 2401 | 0.520 |
Why?
|
| Sequence Analysis, DNA | 7 | 2015 | 866 | 0.510 |
Why?
|
| Myocardium | 1 | 2018 | 571 | 0.510 |
Why?
|
| Herpesvirus 4, Human | 3 | 2015 | 119 | 0.510 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2017 | 195 | 0.500 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 41 | 0.500 |
Why?
|
| Papio | 1 | 2015 | 82 | 0.490 |
Why?
|
| Camptothecin | 1 | 2015 | 196 | 0.490 |
Why?
|
| Genotype | 8 | 2018 | 1849 | 0.480 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 179 | 0.470 |
Why?
|
| Metabolomics | 1 | 2014 | 75 | 0.460 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 82 | 0.460 |
Why?
|
| Olfactory Perception | 1 | 2014 | 21 | 0.450 |
Why?
|
| RNA | 2 | 2020 | 580 | 0.450 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 258 | 0.440 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 739 | 0.440 |
Why?
|
| Alternative Splicing | 3 | 2021 | 211 | 0.440 |
Why?
|
| Genes, rRNA | 1 | 2013 | 7 | 0.430 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2013 | 11 | 0.430 |
Why?
|
| Microbial Consortia | 1 | 2013 | 13 | 0.430 |
Why?
|
| Physiology, Comparative | 1 | 2012 | 4 | 0.420 |
Why?
|
| Seasons | 1 | 2014 | 237 | 0.420 |
Why?
|
| Biological Evolution | 3 | 2020 | 965 | 0.410 |
Why?
|
| Pluripotent Stem Cells | 2 | 2024 | 33 | 0.410 |
Why?
|
| Microbiota | 2 | 2017 | 402 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 2 | 0.410 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 4 | 0.410 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 198 | 0.400 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 98 | 0.400 |
Why?
|
| Social Environment | 1 | 2013 | 187 | 0.400 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 280 | 0.390 |
Why?
|
| Bacteria | 1 | 2015 | 478 | 0.390 |
Why?
|
| Adaptation, Biological | 1 | 2012 | 85 | 0.390 |
Why?
|
| Immunity, Innate | 2 | 2015 | 430 | 0.390 |
Why?
|
| Cell Transformation, Viral | 1 | 2011 | 40 | 0.380 |
Why?
|
| Genetic Speciation | 1 | 2012 | 115 | 0.370 |
Why?
|
| Principal Component Analysis | 4 | 2017 | 160 | 0.370 |
Why?
|
| Lymphocytes | 5 | 2021 | 471 | 0.350 |
Why?
|
| Asthma | 3 | 2016 | 978 | 0.350 |
Why?
|
| DNA | 5 | 2014 | 1308 | 0.340 |
Why?
|
| Chromosome Mapping | 5 | 2017 | 1076 | 0.340 |
Why?
|
| Social Behavior | 1 | 2012 | 299 | 0.330 |
Why?
|
| Behavior, Animal | 1 | 2012 | 378 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 509 | 0.320 |
Why?
|
| Exons | 5 | 2014 | 451 | 0.310 |
Why?
|
| Disease | 1 | 2008 | 90 | 0.300 |
Why?
|
| Feces | 3 | 2015 | 330 | 0.300 |
Why?
|
| Binding Sites | 4 | 2014 | 1117 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 956 | 0.290 |
Why?
|
| Female | 18 | 2022 | 46202 | 0.290 |
Why?
|
| Sex Characteristics | 1 | 2008 | 326 | 0.270 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 2558 | 0.270 |
Why?
|
| Deoxyribonuclease I | 4 | 2012 | 28 | 0.260 |
Why?
|
| Ribosomes | 2 | 2016 | 115 | 0.250 |
Why?
|
| Male | 14 | 2022 | 42411 | 0.250 |
Why?
|
| Molecular Sequence Annotation | 3 | 2014 | 69 | 0.240 |
Why?
|
| Cell Line, Transformed | 3 | 2014 | 155 | 0.240 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2015 | 136 | 0.240 |
Why?
|
| HapMap Project | 3 | 2014 | 47 | 0.240 |
Why?
|
| Cell Culture Techniques | 2 | 2022 | 192 | 0.230 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2415 | 0.230 |
Why?
|
| Protein Binding | 4 | 2015 | 1488 | 0.220 |
Why?
|
| Biology | 1 | 2023 | 52 | 0.220 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 118 | 0.220 |
Why?
|
| Biodiversity | 2 | 2015 | 208 | 0.210 |
Why?
|
| Macrophages | 2 | 2015 | 571 | 0.200 |
Why?
|
| Alleles | 4 | 2015 | 1135 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 695 | 0.200 |
Why?
|
| Bayes Theorem | 5 | 2018 | 370 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2016 | 3385 | 0.190 |
Why?
|
| Gene Dosage | 2 | 2012 | 208 | 0.190 |
Why?
|
| Software | 3 | 2021 | 665 | 0.180 |
Why?
|
| Nigeria | 2 | 2019 | 156 | 0.180 |
Why?
|
| Mice | 9 | 2016 | 11761 | 0.170 |
Why?
|
| Genes, Reporter | 1 | 2020 | 275 | 0.170 |
Why?
|
| Adult | 9 | 2018 | 26607 | 0.170 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 160 | 0.160 |
Why?
|
| Cell Lineage | 2 | 2022 | 291 | 0.160 |
Why?
|
| Olfactory Mucosa | 2 | 2016 | 33 | 0.160 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 2 | 2016 | 38 | 0.160 |
Why?
|
| Endoderm | 1 | 2018 | 24 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2020 | 599 | 0.160 |
Why?
|
| Open Reading Frames | 2 | 2016 | 119 | 0.160 |
Why?
|
| Datasets as Topic | 1 | 2018 | 75 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 104 | 0.150 |
Why?
|
| Base Sequence | 5 | 2020 | 2327 | 0.150 |
Why?
|
| Latent Tuberculosis | 1 | 2017 | 16 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.150 |
Why?
|
| Doxorubicin | 1 | 2018 | 301 | 0.140 |
Why?
|
| Actinobacteria | 1 | 2017 | 11 | 0.140 |
Why?
|
| Nasopharynx | 1 | 2017 | 50 | 0.140 |
Why?
|
| Transcription Initiation Site | 3 | 2012 | 46 | 0.140 |
Why?
|
| Pseudogenes | 2 | 2016 | 34 | 0.140 |
Why?
|
| Immunity, Mucosal | 1 | 2017 | 70 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 78 | 0.140 |
Why?
|
| Lipocalins | 1 | 2016 | 35 | 0.140 |
Why?
|
| Proteomics | 1 | 2018 | 230 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 237 | 0.140 |
Why?
|
| Nose | 1 | 2017 | 94 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 711 | 0.130 |
Why?
|
| Phospholipase D | 1 | 2015 | 13 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2016 | 27 | 0.130 |
Why?
|
| Stromal Cells | 1 | 2016 | 151 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2016 | 89 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 78 | 0.130 |
Why?
|
| Phosphorylation | 1 | 2018 | 1132 | 0.130 |
Why?
|
| Phylogeny | 4 | 2016 | 1187 | 0.130 |
Why?
|
| Response Elements | 1 | 2015 | 65 | 0.130 |
Why?
|
| RNA, Untranslated | 2 | 2012 | 65 | 0.130 |
Why?
|
| Common Cold | 1 | 2015 | 13 | 0.130 |
Why?
|
| Chemotaxis | 1 | 2015 | 73 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 74 | 0.130 |
Why?
|
| 3' Flanking Region | 1 | 2014 | 5 | 0.120 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 16 | 0.120 |
Why?
|
| Molecular Structure | 1 | 2015 | 290 | 0.120 |
Why?
|
| Sequence Analysis | 2 | 2012 | 26 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 187 | 0.120 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 413 | 0.120 |
Why?
|
| Freezing | 1 | 2014 | 32 | 0.120 |
Why?
|
| RNA Splicing | 1 | 2016 | 152 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2016 | 661 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2019 | 1097 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 125 | 0.120 |
Why?
|
| Neoplasm Metastasis | 2 | 2016 | 1109 | 0.120 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 1 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2015 | 184 | 0.110 |
Why?
|
| Cooking | 1 | 2014 | 56 | 0.110 |
Why?
|
| Databases, Genetic | 2 | 2012 | 263 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 306 | 0.110 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 57 | 0.110 |
Why?
|
| Genes | 1 | 2014 | 305 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 294 | 0.110 |
Why?
|
| Mitochondria | 1 | 2017 | 553 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 152 | 0.110 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 4 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2016 | 755 | 0.110 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 26 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2012 | 55 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2016 | 689 | 0.100 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 773 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 277 | 0.100 |
Why?
|
| Darkness | 1 | 2011 | 49 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2758 | 0.100 |
Why?
|
| Lemur | 1 | 2011 | 14 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 540 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 67 | 0.100 |
Why?
|
| Genetic Complementation Test | 2 | 2008 | 97 | 0.100 |
Why?
|
| Omentum | 1 | 2012 | 73 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1942 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 463 | 0.100 |
Why?
|
| RNA Interference | 1 | 2012 | 376 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1265 | 0.090 |
Why?
|
| Diet | 1 | 2014 | 442 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 421 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2013 | 423 | 0.090 |
Why?
|
| Viral Load | 1 | 2011 | 145 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 299 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 92 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2013 | 322 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1652 | 0.080 |
Why?
|
| Middle Aged | 6 | 2017 | 25974 | 0.080 |
Why?
|
| Monocytes | 1 | 2010 | 218 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 293 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1870 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 1242 | 0.080 |
Why?
|
| Testis | 1 | 2009 | 152 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 971 | 0.080 |
Why?
|
| Lung | 2 | 2016 | 1263 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 551 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1877 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 249 | 0.070 |
Why?
|
| Sex Factors | 1 | 2009 | 1066 | 0.070 |
Why?
|
| Young Adult | 3 | 2017 | 6312 | 0.070 |
Why?
|
| RNA, Neoplasm | 2 | 2016 | 88 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 764 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2016 | 815 | 0.060 |
Why?
|
| Kidney | 1 | 2009 | 1147 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1549 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 3011 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 79 | 0.050 |
Why?
|
| Terminator Regions, Genetic | 2 | 2012 | 14 | 0.050 |
Why?
|
| RNA Splice Sites | 2 | 2010 | 57 | 0.040 |
Why?
|
| Primitive Streak | 1 | 2018 | 2 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 3027 | 0.040 |
Why?
|
| Introns | 2 | 2010 | 299 | 0.040 |
Why?
|
| France | 1 | 2017 | 49 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 25 | 0.030 |
Why?
|
| Time Factors | 2 | 2018 | 5338 | 0.030 |
Why?
|
| Mycobacterium smegmatis | 1 | 2015 | 6 | 0.030 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2015 | 6 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2016 | 114 | 0.030 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2016 | 39 | 0.030 |
Why?
|
| Staphylococcus epidermidis | 1 | 2015 | 15 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 34 | 0.030 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 163 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.030 |
Why?
|
| Cyclohexanes | 1 | 2015 | 9 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 16 | 0.030 |
Why?
|
| HMGA2 Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 129 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 275 | 0.030 |
Why?
|
| Integrin alpha2 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2015 | 5 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 370 | 0.030 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2015 | 9 | 0.030 |
Why?
|
| STAT2 Transcription Factor | 1 | 2015 | 6 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 102 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 169 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 157 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2015 | 112 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 251 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 102 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2014 | 41 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 69 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 128 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 247 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 96 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 373 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2014 | 74 | 0.030 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 18 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 207 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 112 | 0.030 |
Why?
|
| Artifacts | 1 | 2015 | 247 | 0.030 |
Why?
|
| Cells | 1 | 2013 | 32 | 0.030 |
Why?
|
| Haplotypes | 1 | 2015 | 637 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2017 | 681 | 0.030 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 8 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 404 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1088 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2012 | 31 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 1214 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 1901 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2012 | 40 | 0.030 |
Why?
|
| Statistical Distributions | 1 | 2012 | 9 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 37 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1862 | 0.030 |
Why?
|
| Madagascar | 1 | 2011 | 28 | 0.030 |
Why?
|
| Endangered Species | 1 | 2011 | 24 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 306 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 131 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 177 | 0.020 |
Why?
|
| Nucleotides | 1 | 2011 | 97 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 5 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2010 | 7 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 227 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 787 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 282 | 0.020 |
Why?
|
| Dogs | 1 | 2011 | 704 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 794 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 65 | 0.020 |
Why?
|
| Internet | 1 | 2012 | 319 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1057 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 887 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 825 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 392 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3783 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3218 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 9263 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 19165 | 0.010 |
Why?
|